BMS-751324

• Description:

  BMS-751324 is a novel clinical prodrug of BMS-582949, which is a highly selective p38α MAPK inhibitor with IC50 of 13 nM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  694.638

• Molecular Formula:

  C32H35N6O10P

• Notes:

  Research use only, not for human use.

• Receptor:

  P38 MAPK

• CAS Number:

  948842-66-8